BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lee EY, Wong CS, Fung SL, Yan PK, Ho JC. SUV as an adjunct in evaluating disease activity in idiopathic pulmonary fibrosis - a pilot study. Nucl Med Commun 2014;35:631-7. [PMID: 24472818 DOI: 10.1097/MNM.0000000000000083] [Cited by in Crossref: 17] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Peelen DM, Zwezerijnen BGJC, Nossent EJ, Meijboom LJ, Hoekstra OS, Van der Laken CJ, Voskuyl AE. The quantitative assessment of interstitial lung disease with positron emission tomography scanning in systemic sclerosis patients. Rheumatology (Oxford) 2020;59:1407-15. [PMID: 31642912 DOI: 10.1093/rheumatology/kez483] [Cited by in Crossref: 9] [Cited by in F6Publishing: 5] [Article Influence: 4.5] [Reference Citation Analysis]
2 Justet A, Laurent-Bellue A, Thabut G, Dieudonné A, Debray MP, Borie R, Aubier M, Lebtahi R, Crestani B. [18F]FDG PET/CT predicts progression-free survival in patients with idiopathic pulmonary fibrosis. Respir Res 2017;18:74. [PMID: 28449678 DOI: 10.1186/s12931-017-0556-3] [Cited by in Crossref: 38] [Cited by in F6Publishing: 37] [Article Influence: 7.6] [Reference Citation Analysis]
3 Ledoult E, Morelle M, Soussan M, Mékinian A, Béhal H, Sobanski V, Hachulla E, Huglo D, Le Gouellec N, Remy-Jardin M, Baillet C, Launay D. 18F-FDG positron emission tomography scanning in systemic sclerosis-associated interstitial lung disease: a pilot study. Arthritis Res Ther 2021;23:76. [PMID: 33673861 DOI: 10.1186/s13075-021-02460-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
4 Liang J, Cao H, Liu Y, Ye B, Sun Y, Ke Y, He Y, Xu B, Lin J. The lungs were on fire: a pilot study of 18F-FDG PET/CT in idiopathic-inflammatory-myopathy-related interstitial lung disease. Arthritis Res Ther 2021;23:198. [PMID: 34301306 DOI: 10.1186/s13075-021-02578-9] [Reference Citation Analysis]
5 Yoon HY, Lee SH, Ha S, Ryu JS, Song JW. The Value of 18F-FDG PET/CT in Evaluating Disease Severity and Prognosis in Idiopathic Pulmonary Fibrosis Patients. J Korean Med Sci 2021;36:e257. [PMID: 34697928 DOI: 10.3346/jkms.2021.36.e257] [Reference Citation Analysis]
6 Flechsig P, Hural O, Kreuter M, Eichhorn M, HEUßEL G, Sachpekidis C, Kauczor HU, Haberkorn U, Heussel CP, Eichinger M. Impact of FDG-PET on the Detection of Patients with Lung Cancer at High Risk for ILD. In Vivo 2018;32:1457-62. [PMID: 30348701 DOI: 10.21873/invivo.11399] [Cited by in Crossref: 1] [Article Influence: 0.3] [Reference Citation Analysis]
7 Bondue B, Castiaux A, Van Simaeys G, Mathey C, Sherer F, Egrise D, Lacroix S, Huaux F, Doumont G, Goldman S. Absence of early metabolic response assessed by 18F-FDG PET/CT after initiation of antifibrotic drugs in IPF patients. Respir Res 2019;20:10. [PMID: 30646908 DOI: 10.1186/s12931-019-0974-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 4.7] [Reference Citation Analysis]
8 Weatherley ND, Eaden JA, Stewart NJ, Bartholmai BJ, Swift AJ, Bianchi SM, Wild JM. Experimental and quantitative imaging techniques in interstitial lung disease. Thorax 2019;74:611-9. [PMID: 30886067 DOI: 10.1136/thoraxjnl-2018-211779] [Cited by in Crossref: 22] [Cited by in F6Publishing: 17] [Article Influence: 7.3] [Reference Citation Analysis]
9 Yoon HY, Lee SH, Ha S, Ryu JS, Song JW. 18F-FDG PET/CT predicts acute exacerbation in idiopathic pulmonary fibrosis after thoracic surgery. BMC Pulm Med 2021;21:294. [PMID: 34530787 DOI: 10.1186/s12890-021-01659-4] [Reference Citation Analysis]